INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 419m ago
HOUSE PTR18m ago
SEC 13F18m ago
ROBINHOOD CHAIN18m ago
Corporate insider
GB

Grow Brian

Chief Commercial OfficerCIK 0001759142

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 0
Max Insider Score24
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Option exercise
M—
958 sh
Jan 10, 2025Apr 24, 2026
traded Jan 10, 2025
+469dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Organogenesis Holdings Inc.Chief Commercial Officer · Feb 18, 2026
24
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Option exercise
M
$1,188
958 sh
Jan 10, 2025
Apr 24, 2026
traded Jan 10, 2025
+469d
SEC FORM 4

Evidence

17
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
234.4K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

13
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
48.3K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$45K
11.8K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

9
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Grant or award
A—
133.6K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC FORM 4

Evidence

18
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$71K
18.9K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$42K
11.1K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$39K
10.6K sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence

15
GB
Grow BrianChief Commercial Officer
ORGOOrganogenesis Holdings Inc.
Tax withholding
F$12K
3,346 sh
Feb 15, 2026Feb 18, 2026
traded Feb 15, 2026
+3dSEC FORM 4

Evidence